Evidence map›Paper›PMID 36073784›Full record

ArticleeLife2022

Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered agonist-mediated activation mechanism.

James P Bridges, Caterina Safina, Bernard Pirard, Kari Brown, Alyssa Filuta, Ravichandran Panchanathan, Rochdi Bouhelal, Nicole Reymann, Sejal Patel, Klaus Seuwen and 2 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Adhesion G protein-coupled receptors.Pharmacological reviews · 2026
    Review
  3. Article
  4. GαInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

James P BridgesDepartment of Pediatrics, Perinatal Institute, Section of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States.ORCID 0000-0002-4815-117X
Caterina SafinaNovartis Institutes for Biomedical Research, Basel, Switzerland.
Bernard PirardNovartis Institutes for Biomedical Research, Basel, Switzerland.
Kari BrownDepartment of Pediatrics, Perinatal Institute, Section of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States.
Alyssa FilutaDepartment of Pediatrics, Perinatal Institute, Section of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States.
Ravichandran PanchanathanDepartment of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, United States.
Rochdi BouhelalNovartis Institutes for Biomedical Research, Basel, Switzerland.
Nicole ReymannNovartis Institutes for Biomedical Research, Basel, Switzerland.
Sejal PatelNovartis Institutes for Biomedical Research, Cambridge, United States.
Klaus SeuwenNovartis Institutes for Biomedical Research, Basel, Switzerland.
William E MillerDepartment of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, United States.
Marie-Gabrielle LudwigNovartis Institutes for Biomedical Research, Basel, Switzerland.ORCID 0000-0002-7799-4782
Novartis (Switzerland) · CHCincinnati Children's Hospital Medical Center · USUniversity of Cincinnati Medical Center · US

Funding

Role of GPR116 in Alveolar HomeostasisR01HL131634 · NHLBI · NATIONAL JEWISH HEALTH · PI BRIDGES, JAMES PATRICK · 2016 to 2020
$2.0M
NHLBI NIH HHS R01 HL131634
6 · The paper itself

Abstract

The mechanistic details of the tethered agonist mode of activation for the adhesion GPCR ADGRF5/GPR116 have not been completely deciphered. We set out to investigate the physiological importance of autocatalytic cleavage upstream of the agonistic peptide sequence, an event necessary for NTF displacement and subsequent receptor activation. To examine this hypothesis, we characterized tethered agonist-mediated activation of GPR116 in vitro and in vivo. A knock-in mouse expressing a non-cleavable GPR116 mutant phenocopies the pulmonary phenotype of GPR116 knock-out mice, demonstrating that tethered agonist-mediated receptor activation is indispensable for function in vivo. Using site-directed mutagenesis and species-swapping approaches, we identified key conserved amino acids for GPR116 activation in the tethered agonist sequence and in extracellular loops 2/3 (ECL2/3). We further highlight residues in transmembrane 7 (TM7) that mediate stronger signaling in mouse versus human GPR116 and recapitulate these findings in a model supporting tethered agonist:ECL2 interactions for GPR116 activation.

Indexed as

Pulmonary SurfactantsAmino AcidsAnimalsHumansMiceMice, KnockoutPeptidesReceptors, G-Protein-CoupledSignal TransductionAmino AcidsGpr116 protein, mousePeptidesPulmonary SurfactantsReceptors, G-Protein-Coupledadhesion GPCR ADGRF5autocatalytic GPS cleavagecell biologyhumanmodelingmousepulmonary surfactanttethered agonist activation

Identifiers

PMID36073784
PMCPMC9489211
OpenAlexW4294992164

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.